Cargando…

BRAF(V600E) inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells

Although BRAF(V600E) mutation is associated with adverse clinical outcomes in patients with colorectal cancer (CRC), response and resistance mechanisms for therapeutic BRAF(V600E) inhibitors remains poorly understood. In the present study, we demonstrate that selective BRAF(V600E) inhibition activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sueda, Toshinori, Sakai, Daisuke, Kawamoto, Koichi, Konno, Masamitsu, Nishida, Naohiro, Koseki, Jun, Colvin, Hugh, Takahashi, Hidekazu, Haraguchi, Naotsugu, Nishimura, Junichi, Hata, Taishi, Takemasa, Ichiro, Mizushima, Tsunekazu, Yamamoto, Hirofumi, Satoh, Taroh, Doki, Yuichiro, Mori, Masaki, Ishii, Hideshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707439/ https://www.ncbi.nlm.nih.gov/pubmed/26750638 http://dx.doi.org/10.1038/srep18949

Ejemplares similares

Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer
por: Colvin, Hugh, et al.
Publicado: (2016)

Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer
por: Miyo, Masaaki, et al.
Publicado: (2016)

Oncogene c-Myc promotes epitranscriptome m(6)A reader YTHDF1 expression in colorectal cancer
por: Nishizawa, Yujiro, et al.
Publicado: (2017)

Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer
por: Yukimoto, Ryohei, et al.
Publicado: (2021)

Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer
por: Hata, Tsuyoshi, et al.
Publicado: (2017)

Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis
por: Hamabe, Atsushi, et al.
Publicado: (2014)

Involvement of MAF1 homolog, negative regulator of RNA polymerase III in colorectal cancer progression
por: Hokonohara, Kentaro, et al.
Publicado: (2019)

Low expression of the GOPC is a poor prognostic marker in colorectal cancer
por: Ohara, Nobuyoshi, et al.
Publicado: (2017)

Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis
por: Koseki, Jun, et al.
Publicado: (2018)

A case of adenocarcinoma arising in an ileal diverticulum resected by laparoscopic surgery
por: Ikeshima, Ryo, et al.
Publicado: (2016)

Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer
por: Osawa, Hideki, et al.
Publicado: (2016)

Factors predictive of high-output ileostomy: a retrospective single-center comparative study
por: Takeda, Mitsunobu, et al.
Publicado: (2018)

Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn’s disease: a case report
por: Takeyama, Hiroshi, et al.
Publicado: (2013)

Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance
por: Takaoka, Yuji, et al.
Publicado: (2019)

Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer
por: Mokutani, Yukako, et al.
Publicado: (2016)

Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells
por: Konno, Masamitsu, et al.
Publicado: (2018)

Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2
por: Asai, Ayumu, et al.
Publicado: (2018)

Development of Novel Prognostic Prediction Models including the Prognostic Nutritional Index for Patients with Colorectal Cancer after Curative Resection
por: Sasaki, Masaru, et al.
Publicado: (2019)

Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study
por: Noda, Takehiro, et al.
Publicado: (2022)

Convolutional Neural Network Can Recognize Drug Resistance of Single Cancer Cells
por: Yanagisawa, Kiminori, et al.
Publicado: (2020)

CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
por: Tsunekuni, Kenta, et al.
Publicado: (2019)

Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study
por: Mizushima, Tsunekazu, et al.
Publicado: (2019)

Comprehensive profiling of novel epithelial–mesenchymal transition mediators and their clinical significance in colorectal cancer
por: Ishikawa, Satoshi, et al.
Publicado: (2021)

A Trans-omics Mathematical Analysis Reveals Novel Functions of the Ornithine Metabolic Pathway in Cancer Stem Cells
por: Koseki, Jun, et al.
Publicado: (2016)

Distinct methylation levels of mature microRNAs in gastrointestinal cancers
por: Konno, Masamitsu, et al.
Publicado: (2019)

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer
por: Hiraki, Masayuki, et al.
Publicado: (2015)

Targeting cancer stem cells in refractory cancer
por: Miyoshi, Norikatsu, et al.
Publicado: (2021)

Sox2 is associated with cancer stem-like properties in colorectal cancer
por: Takeda, Koki, et al.
Publicado: (2018)

Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)
por: Nishizawa, Yujiro, et al.
Publicado: (2021)

Usefulness of Bacterial Culture of Drainage Fluid for Predicting Surgical Site Infection After Crohn’s Disease Surgery
por: Ichihara, Momoko, et al.
Publicado: (2021)

A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection
por: Saso, Kazuhiro, et al.
Publicado: (2019)

Tumour-suppressive function of SIRT4 in human colorectal cancer
por: Miyo, M, et al.
Publicado: (2015)

A Four-Dimensional Organoid System to Visualize Cancer Cell Vascular Invasion
por: Yanagisawa, Kiminori, et al.
Publicado: (2020)

Susceptibility of pancreatic cancer stem cells to reprogramming
por: Noguchi, Kozo, et al.
Publicado: (2015)

Long-term outcome of adrenalectomy for metastasis resulting from colorectal cancer with other metastatic sites: A report of 3 cases
por: Uemura, Mamoru, et al.
Publicado: (2016)

A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
por: Matsuda, Chu, et al.
Publicado: (2022)

A novel physical colonoscopy simulator based on analysis of data from computed tomography colonography
por: Noda, Katsuhisa, et al.
Publicado: (2017)

Theoretical analyses and experimental validation of the effects caused by the fluorinated substituent modification of DNA
por: Koseki, Jun, et al.
Publicado: (2020)

Single-site laparoscopic colectomy for rectosigmoid cancer with middle aortic syndrome: report of a case
por: Tamai, Koki, et al.
Publicado: (2015)

Computational analyses for cancer biology based on exhaustive experimental backgrounds
por: Koseki, Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1es6qqsbntt9897k7ovbqcagm4